NanoVibronix, Inc.
NAOV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $3 | $2 | $1 | $2 |
| % Growth | 12% | 203.6% | -55.6% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $2 | $2 | $0 | $1 |
| % Margin | 59% | 67.3% | 22.2% | 45.4% |
| R&D Expenses | $1 | $0 | $0 | $0 |
| G&A Expenses | $3 | $4 | $4 | $5 |
| SG&A Expenses | $4 | $5 | $5 | $6 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $6 |
| Operating Income | -$4 | -$3 | -$5 | -$6 |
| % Margin | -140% | -150.5% | -666.5% | -335.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$9 |
| Pre-Tax Income | -$4 | -$4 | -$5 | -$14 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$4 | -$5 | -$14 |
| % Margin | -144.8% | -162.5% | -724.5% | -842.6% |
| EPS | -13.73 | -21.2 | -38.4 | -113.5 |
| % Growth | 35.2% | 44.8% | 66.2% | – |
| EPS Diluted | -13.73 | -21.2 | -38.4 | -113.5 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$4 | -$5 | -$14 |
| % Margin | -144.1% | -155.3% | -719.7% | -840.6% |